TORIX DISPOSABLE MARKING & ALIGNMENT SYSTEM: An exciting new surgical product to assist eye surgeons & their patients achieve better outcomes

The Torix ™ Disposable Marking and Alignment System

The Torix ™ Disposable Marking and Alignment System was developed by Eye Surgeon, Dr Peter Macken (M.B.B.S, F.R.A.N.Z.C.O., F.R.A.CS), to provide fellow surgeons with a low cost sterile Pre-operative marker that facilitates faster workflow.

Torix Sterile Packaging

Improved Workflow

The Torix™ Disposable Marking and Alignment System is packaged sterile and ready to use when you are. There is no waiting for instruments to be re sterilised between cases resulting in less downtime for a busy high volume cataract list. Nursing and CSD (Central Sterilising Department) staff are not tied up washing, (continued)

Torix Surgical Eye Marker

Improved Confidence in Marking and Alignment

The Torix™ Disposable Pre-Operative Marker has been designed to optimally pick up and transfer gentian violet ink from sterile marking pens or ink pads. There is less risk of over inking (obscuring the surgical view).

Happy Torix Couple

Less Risk to Patients of Contamination and Cross-Infection

Any instrument that is re used is at risk of contamination if there is a breakdown of infection control standards. Items that have been sterilized by low temperature peracetic acid are at risk of contamination if not used immediately after sterilization (1)

Cost Benefit Torix Silver Dollar

Cost Benefit Analysis

Re usable instruments may cost up to $1,000 per set (for the preoperative marker and the intraoperative axis guide). 5-10 sets may be required for a busy unit with an outlay of $5000. Over time these sets are at risk of breaking from the multiple times handling is required, and loss of visible degree lines on the intraoperative axis guides. This will require further instrument set purchases.

Dr Peter Macken

The Inventor Dr Macken

Graduated from UNSW in 1986, and trained at Sydney Eye Hospital, obtaining his specialist qualifications (Fellowship in Ophthalmology: FRANZCO, FRACS) in 1992. Dr Macken undertook a 12 month Fellowship at the (Continued)